EFL-501 has a novel therapeutic potential for muscle-wasting diseases related to aging, chronic diseases, cachexia and acute muscle wasting diseases by increasing lean body mass and physical function. EFL-501 is likely to be beneficial to extend to various indications which can improve quality of life and reduce morbidity and mortality.